-
Specifically, Tekturna was associated with an increased risk of non-fatal stroke, renal complications, hyperkalemia, and hypotension .
FORBES: ALTITUDE Study of Aliskiren Terminated Early by Novartis
-
Although much more research is needed, this task has the potential to screen for those most at risk of a severe or fatal stroke before it occurs so that they can benefit from preventative treatments.
BBC: Strokes: Drawing test 'may predict risks in older men'
-
The action was based on the recommendation of the independent Data Monitoring Committee (DMC), after it found an increased risk for non-fatal stroke, renal complications, hyperkalemia, and hypotension in patients taking aliskiren after 18-24 months.
FORBES: ALTITUDE Study of Aliskiren Terminated Early by Novartis
-
Neuerburg suffered a fatal stroke shortly afterwards.
FORBES: Charity begins with a commission
-
While niacin showed no difference from placebo in the death rate of the men in this study, fewer patients on niacin had a non-fatal heart attack or stroke, by 26% and 24%, respectively.
FORBES: Niacin, Statins And Difficulties Of Drug Discovery
-
The primary endpoint was the time to first major vascular event, defined as the composite of non-fatal MI or coronary death, any stroke or any arterial revascularization.
FORBES: HPS2-THRIVE: A 'Disappointing But Clear' Result
-
Slightly more than 6 percent of the participants had a heart attack, stroke, or other cardiovascular emergency during the study, roughly one-third of which were fatal.
CNN: Huh? Low-salt diet ups risk of fatal heart attack?